Ventec Life Systems Receives FDA 510(k) Clearance of VOCSN

Ventec Life Systems

Ventec Life Systems has announced 510(k) clearance from the U.S. Food and Drug Administration for VOCSN, the only portable life support device to combine five respiratory therapies – Ventilation, Oxygen, Cough, Suction, and Nebulization (VOCSN, pronounced VOX-SEN).

VOCSN works across the continuum of care, from the hospital to home, and for pediatric patients weighing more than 5 kg to adults. VOCSN is designed to improve care for patients with neuromuscular disease (e.g., Muscular Dystrophies, ALS), impaired lung function (e.g., COPD, Cystic Fibrosis, Lung Cancers, Emphysema), spinal cord injury, and pediatric development complication (e.g., premature births, Chronic Lung Disease). Patients can get all five therapies or just the mix of therapies needed.

VOCSN is more than 70 percent lighter and smaller than existing machines, features a nine-hour on-board battery, and is controlled through an intuitive touchscreen interface and user-friendly operating system. With VOCSN, caregivers can seamlessly switch between therapies with the touch of a button and no longer need to change the patient circuit between therapies. VOCSN enables caregivers to spend less time managing machines and more time caring for patients.

Following his father’s diagnosis with ALS, Doug DeVries, founder and chief executive officer at Ventec, dedicated his work to creating better solutions for ventilator patients, including the portable LTV Series of ventilators.

“I’ve seen firsthand how improved ventilator technology can enhance the quality of life for patients and caregivers. Our team didn’t want to create just another ventilator, we spent the past five years focused on building a truly integrated solution,” he said.

New technology was developed to provide best-in-class treatment in a smaller, more energy efficient system. VOCSN is engineered and manufactured in the United States with eight pending patents.

Ideas from patients, caregivers, medical professionals, and a team of more than 30 leading engineers inspired VOCSN.

“Since the iron lung, respiratory equipment has limited the mobility of ventilator patients. VOCSN was designed for everyday mobility so that patients can focus on their relationships with loved ones and live their life,” said Richard Branson, professor of surgery, University of Cincinnati and a member of the Ventec Clinical Board.